Medigus Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
Medigus Ltd. (Nasdaq: MDGS) announced that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which necessitates a minimum bid price of $1.00 per ADS.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Medigus Ltd. (Nasdaq: MDGS) announced that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which necessitates a minimum bid price of $1.00 per ADS. This determination follows the Company's ADSs closing at or above $1.00 for 10 consecutive business days. Nasdaq has officially closed the matter regarding the prior bid price deficiency. Based in Israel, Medigus focuses on advanced medical solutions, digital commerce, and electric vehicle technologies.
Positive
- Regained compliance with Nasdaq Listing Rule 5550(a)(2).
- ADSs traded at or above $1.00 for 10 consecutive business days.
Negative
- None.
Details
News Market Reaction – MDGS
The recorded move for MDGS in the trading session of this news was -7.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Tel Aviv, Israel, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, today reported the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Listing Rule 5550(a)(2), which requires the Company's ADSs to maintain a minimum bid price of
The Nasdaq staff made this determination of compliance after the closing bid price of the Company's ADSs was at
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus' affiliations in the medical solutions arena include ownership in Polyrizon Ltd. and ownership in industry 4.0 company, ScoutCam Inc. The Company’s affiliates in digital commerce include Gix Internet Ltd., Jeffs' Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.
Company Contact:
Tali Dinar
Chief Financial Officer
+972-8-6466-880
ir@medigus.com
Investor Relations Contact:
Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
MDGS@redchip.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.